The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
Nirmatrelvir+Ritonavir (Paxlovid) is indicated for the treatment of coronavirus disease 2019 (COVID-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe COVID 19 (see Pharmacology: Pharmacodynamics under Actions).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
